Project Grant T32CA302573
Award Date 7/9/26
Completion Date 6/30/31
Dollars Obligated $564K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute awarded The University of Iowa a $2,185,934 Project Grant on August 28, 2025, under the Cancer Centers Support Grants program (CFDA 93.397) to establish a Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer through July 31, 2030. This award supports innovative translational research addressing neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs)—orphan cancers with increasing prevalence...
- Federal Grant Award Summary The University of Iowa received a $155,500 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded July 18, 2025, with a completion date of June 30, 2027. The grant supports research establishing an in vivo Sleeping Beauty (SB) transposon mutagenesis screen in a nevi-prone zebrafish model to identify and characterize novel genetic drivers of melanomagenesis. The research addresses a critical...
- Federal Project Grant Award Summary The University of Iowa received a $628,280 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective April 1, 2026, through March 31, 2031. This award funds research to develop novel therapeutic approaches targeting C-X-C chemokine receptor 4 (CXCR4) combined with redox metabolism inhibition for treatment of pulmonary neuroendocrine tumors and carcinomas, including atypical carcinoids and...
- NextGen Oncology Scholars Program Summary Wayne State University received a $159,450 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective August 15, 2025 through July 31, 2030. The award funds the "NextGen Oncology Scholars: Nurturing Tomorrow's Pioneers" program, which provides structured educational and research training for undergraduate scholars to prepare them for graduate studies and careers in cancer...
- The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
- The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The University of Iowa was awarded an $810,971 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The award will fund research from April 2021 through April 2024 to target a protumorigenic immunosuppressive loop in malignant peripheral nerve sheath tumors (MPNST). The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions for...
- The University of Iowa was awarded a $1,354,009 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, which runs from September 1, 2024 to August 31, 2027, aims to develop clinically deliverable RNA strategies for radiation protection. Specifically, the project will leverage the protective qualities of extremophile proteins and new delivery methods to reduce the impact of radiation-induced injuries...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Oklahoma Health Sciences Center a $361,695 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective September 1, 2025, through August 31, 2029. This NCI Research Specialist (Clinician Scientist) Award supports an Associate Professor of Urologic Oncology who serves as the Stevenson Chair at the Stephenson Cancer Center to advance cancer screening and clinical trial enrollment...
- Federal Grant Award Summary The University of Iowa received a $560,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to develop a novel theranostic strategy for pancreatic neuroendocrine tumors. The award, effective September 1, 2026, through August 31, 2028, supports biomedical research aimed at advancing medical solutions and healthcare outcomes for Service Members and the American public. This project...